货号:A464388
同义名:
CHF5074; CSP-1103
CHF5074 is a γ-secretase modulator, reduces Aβ42 and Aβ40 secretion, with an IC50 of 3.6 and 18.4 μM, respectively.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Itanapraced (CHF5074) is an orally active γ-secretase modulator and a non-steroidal anti-inflammatory derivative. It reduces Aβ42 and Aβ40 secretion with IC50 values of 3.6 and 18.4 μM, respectively, and prevents cell apoptosis in hippocampal neurons caused by oxygen and glucose deprivation (OGD). Itanapraced is researched for potential use in Alzheimer's disease treatment[1][2]. |
Animal study | Itanapraced, when given orally at 375 ppm in the diet for 17 weeks, lowers both Aβ42 and Aβ40 levels and reduces brain plaque burden in Tg2576 transgenic mice[1]. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.08mL 0.62mL 0.31mL |
15.38mL 3.08mL 1.54mL |
30.75mL 6.15mL 3.08mL |
CAS号 | 749269-83-8 |
分子式 | C16H11Cl2FO2 |
分子量 | 325.16 |
SMILES Code | O=C(C1(C2=CC=C(C3=CC=C(Cl)C(Cl)=C3)C(F)=C2)CC1)O |
MDL No. | MFCD18633206 |
别名 | CHF5074; CSP-1103; CS 1103 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |